These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. A retrospective study of left ventricular assist device-related infections. Bentz B; Hupcey JE; Polomano RC; Boehmer JP J Cardiovasc Manag; 2004; 15(1):9-16. PubMed ID: 14976692 [TBL] [Abstract][Full Text] [Related]
27. A simple education tool for ventricular assist device patients and their caregivers. Barber J; Leslie G J Cardiovasc Nurs; 2015; 30(3):E1-E10. PubMed ID: 24671032 [TBL] [Abstract][Full Text] [Related]
28. Topical Polymyxin-Trimethoprim Prophylaxis May Decrease the Incidence of Driveline Infections in Patients With Continuous-Flow Left Ventricular Assist Devices. Durand ML; Ennis SC; Baker JN; Camuso JM; McEachern KM; Kotton CN; Lewis GD; Garcia JP; MacGillivray TE Artif Organs; 2017 Feb; 41(2):169-175. PubMed ID: 27098102 [TBL] [Abstract][Full Text] [Related]
29. Prevention, treatment and outcomes of left ventricular assist device driveline infections. A single Center experience. Putnik S; Terzić D; Nestorović E; Karan R; Dobri M; Andrijasević V; Zlatkovic M; Kostić NK; Velinovic M; Ivanisevic D; Ristić M Ann Ital Chir; 2020; 91():8-15. PubMed ID: 32180572 [TBL] [Abstract][Full Text] [Related]
30. Variability in infection control measures for the percutaneous lead among programs implanting long-term ventricular assist devices in the United States. Cannon A; Elliott T; Ballew C; Cavey J; O'Shea G; Franzwa J; Puhlman M; Bennett J; Ryan T; Lockard K; Avrahami N; Brennan P; Kurien S; Andrus S; Dick S; Davis E Prog Transplant; 2012 Dec; 22(4):351-9. PubMed ID: 23187051 [TBL] [Abstract][Full Text] [Related]
31. Driveline infections in patients supported with a HeartMate II: incidence, aetiology and outcome. Bomholt T; Moser C; Sander K; Boesgaard S; Køber L; Olsen PS; Hansen PB; Mortensen SA; Gustafsson F Scand Cardiovasc J; 2011 Oct; 45(5):273-8. PubMed ID: 21539474 [TBL] [Abstract][Full Text] [Related]
32. Outcomes of Heart Transplant After Left Ventricular Assist Device Specific and Related Infection. Tong MZ; Smedira NG; Soltesz EG; Starling RC; Koval CE; Porepa L; Moazami N Ann Thorac Surg; 2015 Oct; 100(4):1292-7. PubMed ID: 26188972 [TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices. Jennings DL; Chopra A; Chambers R; Morgan JA Artif Organs; 2014 Oct; 38(10):875-9. PubMed ID: 24571683 [TBL] [Abstract][Full Text] [Related]
34. Minimum inhibitory concentration changes in relapsed left ventricular assist device driveline infections. Lines TH; Sabato LA; Nesbitt WJ; Moretz JD; Brinkley DM; Satyanarayana G Int J Artif Organs; 2020 Jul; 43(7):494-499. PubMed ID: 31964206 [TBL] [Abstract][Full Text] [Related]
35. Treatment of HeartMate III-LVAD driveline infection by negative pressure wound therapy: Result of our case series. Cikirikcioglu M; Ponchant K; Murith N; Meyer P; Yilmaz N; Huber C Int J Artif Organs; 2021 Nov; 44(11):912-916. PubMed ID: 34558333 [TBL] [Abstract][Full Text] [Related]
36. Obesity and left ventricular assist device driveline exit site infection. Raymond AL; Kfoury AG; Bishop CJ; Davis ES; Goebel KM; Stoker S; Selzman CH; Clayson SE; Smith H; Cowley CG; Alharethi R; Budge D; Reid BB ASAIO J; 2010; 56(1):57-60. PubMed ID: 20051832 [TBL] [Abstract][Full Text] [Related]
37. Surgical management of driveline infections in patients with left ventricular assist devices. Pieri M; Scandroglio AM; Müller M; Pergantis P; Kretzschmar A; Kaufmann F; Falk V; Krabatsch T; Arlt G; Potapov E; Kukucka M J Card Surg; 2016 Dec; 31(12):765-771. PubMed ID: 27766677 [TBL] [Abstract][Full Text] [Related]
38. Importance of early appropriate intervention including antibiotics and wound care for device-related infection in patients with left ventricular assist device. Hieda M; Sata M; Seguchi O; Yanase M; Murata Y; Sato T; Sunami H; Nakajima S; Watanabe T; Hori Y; Wada K; Hata H; Fujita T; Kobayashi J; Nakatani T Transplant Proc; 2014 Apr; 46(3):907-10. PubMed ID: 24767378 [TBL] [Abstract][Full Text] [Related]
39. Wound care of the driveline exit site in patients with a ventricular assist device: A systematic review. Özdemir Z; Şenol Çelik S Turk Gogus Kalp Damar Cerrahisi Derg; 2018 Apr; 26(2):328-335. PubMed ID: 32082759 [TBL] [Abstract][Full Text] [Related]
40. Prophylactic negative pressure wound therapy is not effective for preventing driveline infection following left ventricular assist device implantation. Tsuji M; Kakuda N; Bujo C; Saito A; Ishida J; Amiya E; Hatano M; Shimada A; Imai H; Kimura M; Ando M; Kinoshita O; Yamauchi H; Komuro I; Ono M Artif Organs; 2023 Mar; 47(3):566-573. PubMed ID: 36300650 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]